<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01500902</url>
  </required_header>
  <id_info>
    <org_study_id>09-000047</org_study_id>
    <nct_id>NCT01500902</nct_id>
  </id_info>
  <brief_title>Prediction of Cardiovascular Events in Vulnerable Patients Following Acute Coronary Syndrome</brief_title>
  <official_title>The Assessment of Novel Functional Risk Factors for the Prediction of Cardiovascular Events in Vulnerable Patients Following Acute Coronary Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Qatar National Research Fund</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if testing patients for endothelial dysfunction
      will help identify which patients are more likely at risk to have another heart attack in the
      future. Study participants will undergo mental stress testing while at the same time being
      connected to a device that measures endothelial function via the Endopat device. These same
      participants will also undergo a sleep study via the Watchpat device.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Unstable Angina, Myocardial Infarction, Repeat Revascularization, Cardiac Death, Stroke</measure>
    <time_frame>Will determine with statistical analysis after all patients have had 2 year follow-up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>6 months post revascularization.</time_frame>
    <description>Quality of Life as assessed by SF12</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">101</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <arm_group>
    <arm_group_label>vascular testing</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>We are assessing vascular testing in patients presenting with acute coronary syndrome to determine if this type of testing will help identify which patients are more likely at risk to have another heart attack.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>EndoPAT testing (non invasive device)</intervention_name>
    <description>Using the EndoPAT device, we will assess endothelial function.</description>
    <arm_group_label>vascular testing</arm_group_label>
    <other_name>Itamar EndoPAT 2000</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>WatchPAT testing (non-invasive device)</intervention_name>
    <description>Using the WATCHPAT device we will assess sleep apnea.</description>
    <arm_group_label>vascular testing</arm_group_label>
    <other_name>Itamar WatchPAT 200</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients undergoing revascularization by percutaneous intervention (PCI) for Acute
             Coronary Syndrome (ACS) at Mayo (STEMI and NonSTEMI patients)

          2. Age greater than 18

        Exclusion Criteria:

          1. Patients likely not to complete the study due to co-morbid conditions (end stage renal
             disease; liver failure; malignancies)

          2. Inability to sign a consent form or availability for follow up

          3. Patients unable to tolerate the blood pressure cuff inflation on both arms

          4. patients with tremors

          5. sustained non-sinus cardiac arrhythmias

          6. acrylic finger nails

          7. permanent pacemaker

          8. color blindness

          9. use of alpha blockers and short acting nitrates &lt; 3 hours before study

         10. Federal Medical Center inmates
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amir Lerman, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 22, 2011</study_first_submitted>
  <study_first_submitted_qc>December 28, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 29, 2011</study_first_posted>
  <last_update_submitted>September 22, 2015</last_update_submitted>
  <last_update_submitted_qc>September 22, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 23, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Amir Lerman</investigator_full_name>
    <investigator_title>M.D., Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Acute Coronary Syndrome (ACS)</keyword>
  <keyword>Percutaneous Intervention (PCI)</keyword>
  <keyword>Coronary Stent (CStent)</keyword>
  <keyword>Percutaneous Transluminal Coronary Angioplasty (PTCA)</keyword>
  <keyword>stent placement</keyword>
  <keyword>balloon angioplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

